{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:30:29Z","timestamp":1793050229539,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110179\/Z\/15\/Z"],"award-info":[{"award-number":["110179\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Adjunctive corticosteroids such as dexamethasone are recommended in tuberculous meningitis treatment, despite modest and heterogeneous survival benefit. Leukotriene A4 hydrolase (\n                    <jats:italic>LTA4H<\/jats:italic>\n                    ) genotypes associate with distinct intracerebral inflammatory phenotypes and may determine corticosteroid response in tuberculous meningitis, with benefit observed in hyperinflammatory TT genotype but uncertain benefit in lower inflammation CC and CT genotypes. Here, in a phase 3, placebo-controlled trial of human immunodeficiency virus-negative Vietnamese adults with tuberculous meningitis, we randomized 613\n                    <jats:italic>LTA4H<\/jats:italic>\n                    CC- and CT-genotype participants to 6\u20138\u2009weeks of dexamethasone or placebo, aiming to show noninferiority of placebo (hazard ratio margin of 0.75) or its superiority. Given the significant survival benefit of dexamethasone previously seen in\n                    <jats:italic>LTA4H<\/jats:italic>\n                    TT-genotype individuals, TT-genotype participants all received open-label dexamethasone and were not randomized. A total of 89 TT-genotype participants received open-label dexamethasone. In CC- and CT-genotype participants, the primary endpoint of all-cause death or new neurological event over 12\u2009months from randomization occurred in 108\/305 (35.4%) given dexamethasone and 110\/308 (35.7%) given placebo (hazard ratio of 0.99, 96% confidence interval (adjusted for multiple testing) 0.748\u20131.31). The number of observed primary endpoints (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009218) exceeded the prespecified number (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009184) used to calculate the trial\u2019s sample size and power. Placebo noninferiority was not established in the CC and CT population or in individual genotype subpopulations. Benefit or heterogeneity of effect was not observed by any prespecified subgroup. In TT-genotype participants, the primary endpoint occurred in 28\/89 (31.5%) participants, similar to CC and CT participants. Outcomes were not significantly better in TT-genotype participants versus CC- or CT-genotype participants. In CC- and CT-genotype participants, serious adverse events occurred in 161\/305 (52.8%) dexamethasone-treated participants and 160\/308 (51.9%) placebo-treated participants. In conclusion, neither noninferiority nor superiority of placebo was established in human immunodeficiency virus-negative\n                    <jats:italic>LTA4H<\/jats:italic>\n                    CC- and CT-genotype adults with tuberculous meningitis, and dexamethasone was safe. The modest and heterogeneous benefit of dexamethasone indicates that greater understanding of tuberculous meningitis pathophysiology is needed, alongside better targeted, more effective anti-inflammatory agents than corticosteroids (ClinicalTrials.gov\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\/study\/NCT03100786\" ext-link-type=\"uri\">NCT03100786<\/jats:ext-link>\n                    ).\n                  <\/jats:p>","DOI":"10.1038\/s41591-025-04138-z","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:05:37Z","timestamp":1768471537000},"page":"849-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-336X","authenticated-orcid":false,"given":"Joseph","family":"Donovan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Duc Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4281-4929","authenticated-orcid":false,"given":"Huu Khanh Trinh","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Trung Nghia","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Anh Thu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thu Hiep","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Bao Ngoc","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Khac Nguyen","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truc Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Hong Hanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieu Nguyet Oanh","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Anh Thu","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Mai Trang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Minh Ha","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huu Lan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-1019","authenticated-orcid":false,"given":"Van Vinh Chau","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Hai","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Dinh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7968-473X","authenticated-orcid":false,"given":"Khanh Lam","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-5533","authenticated-orcid":false,"given":"Lalita","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Hoang Nhat","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy Thuong Thuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Wolbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Kestelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-3155","authenticated-orcid":false,"given":"Ronald B.","family":"Geskus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoan Phu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2858-2087","authenticated-orcid":false,"given":"Guy E.","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"4138_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1474-4422(21)00435-X","volume":"21","author":"J Huynh","year":"2022","unstructured":"Huynh, J. et al. Tuberculous meningitis: progress and remaining questions. Lancet Neurol. 21, 450\u2013464 (2022).","journal-title":"Lancet Neurol."},{"key":"4138_CR2","doi-asserted-by":"publisher","first-page":"e0000069","DOI":"10.1371\/journal.pgph.0000069","volume":"1","author":"PJ Dodd","year":"2021","unstructured":"Dodd, P. J. et al. The global burden of tuberculous meningitis in adults: s modelling study. PLoS Glob. Public Health 1, e0000069 (2021).","journal-title":"PLoS Glob. Public Health"},{"key":"4138_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jinf.2004.02.010","volume":"50","author":"PR Donald","year":"2005","unstructured":"Donald, P. R., Schaaf, H. S. & Schoeman, J. F. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J. Infect. 50, 193\u2013195 (2005).","journal-title":"J. Infect."},{"key":"4138_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.tube.2010.08.005","volume":"90","author":"N Krishnan","year":"2010","unstructured":"Krishnan, N., Robertson, B. D. & Thwaites, G. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis 90, 361\u2013366 (2010).","journal-title":"Tuberculosis"},{"key":"4138_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrneurol.2017.120","volume":"13","author":"RJ Wilkinson","year":"2017","unstructured":"Wilkinson, R. J. et al. Tuberculous meningitis. Nat. Rev. Neurol. 13, 581\u2013598 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"4138_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/cid\/cix849","volume":"66","author":"LTP Thao","year":"2018","unstructured":"Thao, L. T. P. et al. Prognostic models for 9-month mortality in tuberculous meningitis. Clin. Infect. Dis. 66, 523\u2013532 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"4138_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/infdis\/jix050","volume":"215","author":"NTT Thuong","year":"2017","unstructured":"Thuong, N. T. T. et al. Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis. J. Infect. Dis. 215, 1020\u20131028 (2017).","journal-title":"J. Infect. Dis."},{"key":"4138_CR8","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573","volume":"351","author":"GE Thwaites","year":"2004","unstructured":"Thwaites, G. E. et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N. Engl. J. Med. 351, 1741\u20131751 (2004).","journal-title":"N. Engl. J. Med."},{"key":"4138_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4049\/jimmunol.175.1.579","volume":"175","author":"CP Simmons","year":"2005","unstructured":"Simmons, C. P. et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J. Immunol. 175, 579\u2013590 (2005).","journal-title":"J. Immunol."},{"key":"4138_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1474-4422(07)70034-0","volume":"6","author":"GE Thwaites","year":"2007","unstructured":"Thwaites, G. E. et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol. 6, 230\u2013236 (2007).","journal-title":"Lancet Neurol."},{"key":"4138_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cell.2010.02.013","volume":"140","author":"DM Tobin","year":"2010","unstructured":"Tobin, D. M. et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717\u2013730 (2010).","journal-title":"Cell"},{"key":"4138_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","volume":"148","author":"DM Tobin","year":"2012","unstructured":"Tobin, D. M. et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148, 434\u2013446 (2012).","journal-title":"Cell"},{"key":"4138_CR13","doi-asserted-by":"publisher","first-page":"e61722","DOI":"10.7554\/eLife.61722","volume":"10","author":"L Whitworth","year":"2021","unstructured":"Whitworth, L. et al. A Bayesian analysis of the association between Leukotriene A4 Hydrolase genotype and survival in tuberculous meningitis. eLife 10, e61722 (2021).","journal-title":"eLife"},{"key":"4138_CR14","first-page":"CD002244","volume":"4","author":"K Prasad","year":"2016","unstructured":"Prasad, K., Singh, M. B. & Ryan, H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst. Rev. 4, CD002244 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4138_CR15","first-page":"665","volume":"215","author":"NTT Thuong","year":"2017","unstructured":"Thuong, N. T. T. & Thwaites, G. E. Treatment-associated inflammatory deterioration in tuberculous meningitis: unpicking the paradox. J. Infect. Dis. 215, 665\u2013667 (2017).","journal-title":"J. Infect. Dis."},{"key":"4138_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJM195311192492101","volume":"249","author":"SJ Shane","year":"1953","unstructured":"Shane, S. J. & Riley, C. Tuberculous meningitis: combined therapy with cortisone and antimicrobial agents. N. Engl. J. Med. 249, 829\u2013834 (1953).","journal-title":"N. Engl. J. Med."},{"key":"4138_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1542\/peds.99.2.226","volume":"99","author":"JF Schoeman","year":"1997","unstructured":"Schoeman, J. F., Van Zyl, L. E., Laubscher, J. A. & Donald, P. R. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 99, 226\u2013231 (1997).","journal-title":"Pediatrics"},{"key":"4138_CR18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1056\/NEJMoa2216218","volume":"389","author":"J Donovan","year":"2023","unstructured":"Donovan, J. et al. Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults. N. Engl. J. Med. 389, 1357\u20131367 (2023).","journal-title":"N. Engl. J. Med."},{"key":"4138_CR19","doi-asserted-by":"publisher","first-page":"e2024852118","DOI":"10.1073\/pnas.2024852118","volume":"118","author":"LJ Whitworth","year":"2021","unstructured":"Whitworth, L. J. et al. Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone. Proc. Natl Acad. Sci. USA 118, e2024852118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4138_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/ana.26240","volume":"90","author":"OK Siddiqi","year":"2021","unstructured":"Siddiqi, O. K. et al. LTA4H prevalence and mortality in adult Zambians with tuberculous meningitis. Ann. Neurol. 90, 994\u2013998 (2021).","journal-title":"Ann. Neurol."},{"key":"4138_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tube.2010.11.001","volume":"91","author":"J Curtis","year":"2011","unstructured":"Curtis, J. et al. Association analysis of the LTA4H gene polymorphisms and pulmonary tuberculosis in 9115 subjects. Tuberculosis 91, 22\u201325 (2011).","journal-title":"Tuberculosis"},{"key":"4138_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.tube.2014.08.014","volume":"94","author":"J Yang","year":"2014","unstructured":"Yang, J. et al. Relationship between human LTA4H polymorphisms and extra-pulmonary tuberculosis in an ethnic Han Chinese population in Eastern China. Tuberculosis 94, 657\u2013663 (2014).","journal-title":"Tuberculosis"},{"key":"4138_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad379","volume":"10","author":"C Stek","year":"2023","unstructured":"Stek, C. et al. Relationship between LTA4H promotor polymorphism and tuberculosis-associated immune reconstitution inflammatory syndrome and its prevention with prednisone. Open Forum Infect. Dis. 10, ofad379 (2023).","journal-title":"Open Forum Infect. Dis."},{"key":"4138_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/infdis\/jix051","volume":"215","author":"A van Laarhoven","year":"2017","unstructured":"van Laarhoven, A. et al. Clinical parameters, routine inflammatory markers, and LTA4H genotype as predictors of mortality among 608 patients with tuberculous meningitis in indonesia. J. Infect. Dis. 215, 1029\u20131039 (2017).","journal-title":"J. Infect. Dis."},{"key":"4138_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(24)00512-7","volume":"25","author":"S Wasserman","year":"2025","unstructured":"Wasserman, S. et al. Advancing the chemotherapy of tuberculous meningitis: a consensus view. Lancet Infect. Dis. 25, e47\u2013e58 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"4138_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","volume":"10","author":"S Marais","year":"2010","unstructured":"Marais, S. et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect. Dis. 10, 803\u2013812 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"4138_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.12688\/wellcomeopenres.14007.1","volume":"3","author":"J Donovan","year":"2018","unstructured":"Donovan, J. et al. Adjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by leukotriene A4 hydrolase genotype (LAST ACT): Study protocol for a randomised double blind placebo controlled non-inferiority trial. Wellcome Open Res. 3, 32 (2018).","journal-title":"Wellcome Open Res."},{"key":"4138_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.12688\/wellcomeopenres.22498.1","volume":"9","author":"J Donovan","year":"2024","unstructured":"Donovan, J. et al. Statistical analysis plan for the LAST ACT clinical trial; a leukotriene A4 hydrolase stratified non-inferiority trial of adjunctive corticosteroids for HIV-negative adults with tuberculous meningitis. Wellcome Open Res. 9, 695 (2024).","journal-title":"Wellcome Open Res."},{"key":"4138_CR29","doi-asserted-by":"publisher","first-page":"e0118789","DOI":"10.1371\/journal.pone.0118789","volume":"10","author":"SJ Dunstan","year":"2015","unstructured":"Dunstan, S. J. et al. LTA4H genotype is associated with susceptibility to bacterial meningitis but is not a critical determinant of outcome. PLoS ONE 10, e0118789 (2015).","journal-title":"PLoS ONE"},{"key":"4138_CR30","doi-asserted-by":"crossref","unstructured":"Streptomycin in Tuberculosis Trials Committee, Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet 1, 582\u2013596 (1948).","DOI":"10.1016\/S0140-6736(48)92003-0"},{"key":"4138_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1473-3099(19)30649-8","volume":"20","author":"J Donovan","year":"2020","unstructured":"Donovan, J. et al. Xpert MTB\/RIF Ultra versus Xpert MTB\/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect. Dis. 20, 299\u2013307 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"4138_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The SVA package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"4138_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"4138_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"4138_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"4138_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cct.2010.08.011","volume":"31","author":"B Spiessens","year":"2010","unstructured":"Spiessens, B. & Debois, M. Adjusted significance levels for subgroup analyses in clinical trials. Contemp. Clin. Trials 31, 647\u2013656 (2010).","journal-title":"Contemp. Clin. Trials"},{"key":"4138_CR37","unstructured":"R Core Team R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2024)."},{"key":"4138_CR38","doi-asserted-by":"publisher","first-page":"RP92344","DOI":"10.7554\/eLife.92344","volume":"13","author":"HT Hai","year":"2024","unstructured":"Hai, H. T. et al. Whole blood transcriptional profiles and the pathogenesis of tuberculous meningitis. eLife 13, RP92344 (2024).","journal-title":"eLife"},{"key":"4138_CR39","doi-asserted-by":"publisher","unstructured":"Nguyen, T. T. T. Genotype stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: the LAST ACT trial. Dryad https:\/\/doi.org\/10.5061\/dryad.f1vhhmh7v (2025).","DOI":"10.5061\/dryad.f1vhhmh7v"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-04138-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-04138-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-04138-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:02:44Z","timestamp":1774018964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-04138-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-04138-z","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}